AXSM
Axsome Therapeutics Inc
193.50$
-4.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -1,227.1% | -232.8% | -53.6% | -33.3% | -14.6% | |
| – | – | – | – | – | – | – | 0.9% | 8.8% | 2.5% | 2.1% | 1.4% | |
| – | – | – | – | – | – | – | 235.9% | 75.4% | 23.1% | 22.1% | 14.7% | |
| – | – | – | – | – | – | – | 235.8% | 79.8% | – | – | – | |
| – | – | – | – | – | – | – | 3.7% | 47.3% | -10.5% | 8.8% | -3.5% | |
| – | – | – | – | – | – | – | 3.5% | 1.4% | 0.2% | 0.1% | 0.1% | |
| – | – | – | – | – | – | – | -3.5% | -107.3% | -0.2% | -0.1% | -0.1% | |
| – | – | – | – | – | – | – | – | 87.9% | – | – | – | |
| – | – | – | – | – | – | – | -2.0% | -1.1% | -0.7% | – | – | |
| – | – | – | – | – | – | – | -3.5% | 89.9% | 31.4% | -0.3% | -0.6% | |
| – | – | – | – | – | – | – | 126.2% | 568.7% | 122.3% | 15.0% | 15.9% | |
| – | – | – | – | – | – | – | -1,104.4% | 228.6% | 68.5% | -18.4% | 1.2% | |
| – | – | – | – | – | – | – | -1,230.6% | -234.3% | -53.8% | -33.4% | -14.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.